LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 36

Search options

  1. Book ; Online: Chapter 7 Finding the global in the local : Constructing population in the search for disease genes

    Sturdy, Steve

    2020  

    Keywords History of medicine ; Mathematics & science ; International institutions ; human genetic variation ; non-Western populations ; disease aetiology ; association studies ; population genomics
    Size 1 electronic resource (29 pages)
    Publisher Manchester University Press
    Publishing place Manchester
    Document type Book ; Online
    Note English ; Open Access
    HBZ-ID HT021026994
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Article ; Online: Framing utility: Regulatory reform and genetic tests in the USA, 1989-2000.

    Sturdy, Steve

    Social science & medicine (1982)

    2020  Volume 304, Page(s) 112924

    Abstract: Before about 1990, insofar as diagnostic and other medical tests were subject to regulatory oversight, it was chiefly to ensure that they met appropriate standards of analytic and clinical validity. Over the course of the 1990s, however, regulatory ... ...

    Abstract Before about 1990, insofar as diagnostic and other medical tests were subject to regulatory oversight, it was chiefly to ensure that they met appropriate standards of analytic and clinical validity. Over the course of the 1990s, however, regulatory reformers in the United States began to argue that genetic tests, specifically, should also be assessed to determine whether or not they actually benefit those undergoing testing-whether they possess "clinical utility", as they put it. The present paper asks why this shift in regulatory focus occurred specifically in relation to genetic tests, and why clinical utility became a key object of assessment. It answers these questions by situating concerns about genetic tests in the longer history of medical genetics. Looking back to the 1970s and medical geneticists' efforts to distance themselves from their earlier association with eugenics, it shows that they adopted a particular framing of the dangers of genetic testing which would inform their response to the proliferation of new genetic tests and the growth of commercial testing in the 1990s. In a series of policy committees convened over the course of that decade, medical geneticists called for regulatory measures to be implemented to ensure that genetic tests were only introduced into medical practice if they had been shown to be beneficial to those tested. The paper follows the deliberations of those committees to show in detail how geneticists worked within this framing to accommodate new technical capacities and regulatory opportunities. In the course of these deliberations, they adopted the idea of clinical utility to signify the need for evidence of benefit specifically to those tested. The paper concludes with some observations regarding how this framing of genetic tests relates to current understandings of "genetic exceptionalism" and to more recent articulations of clinical utility.
    MeSH term(s) Eugenics ; Genetic Testing ; Humans ; Organizations ; United States
    Language English
    Publishing date 2020-03-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 4766-1
    ISSN 1873-5347 ; 0037-7856 ; 0277-9536
    ISSN (online) 1873-5347
    ISSN 0037-7856 ; 0277-9536
    DOI 10.1016/j.socscimed.2020.112924
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Personalised Medicine and the Economy of Biotechnological Promise.

    Sturdy, Steve

    The New bioethics : a multidisciplinary journal of biotechnology and the body

    2017  Volume 23, Issue 1, Page(s) 30–37

    Abstract: Rather than seek to distinguish hype from legitimate promise, it may be more helpful to think about personalised medicine as embodying a promissory economy which serves both to mobilize resources for research and - partly at least - to determine the ends ...

    Abstract Rather than seek to distinguish hype from legitimate promise, it may be more helpful to think about personalised medicine as embodying a promissory economy which serves both to mobilize resources for research and - partly at least - to determine the ends to which that research is directed. Personalised medicine is a development of the larger promissory economy of medical biotechnology. As such, it systematically conflates public benefit with the pursuit of commercial and especially pharmaceutical interests. Consequently, research and development in personalised medicine tends to favour the production of expensive new treatments over unprofitable forms of prevention or more effective use of older therapies. A rebalancing of research priorities is needed to favour the pursuit of public benefit, even when it does not deliver private profits. This will in turn require sustained reflection, self-criticism and often self-denial on the part of public research funders and the scientists they support.
    MeSH term(s) Biotechnology ; Humans ; Precision Medicine ; Research/trends
    Language English
    Publishing date 2017-05-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2727428-7
    ISSN 2050-2885 ; 2050-2877
    ISSN (online) 2050-2885
    ISSN 2050-2877
    DOI 10.1080/20502877.2017.1314892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Multidisciplinary perspectives on the regulation of diagnostic technologies.

    Hogarth, Stuart / Miller, Fiona A / Sturdy, Steve

    Social science & medicine (1982)

    2022  Volume 304, Page(s) 115059

    MeSH term(s) Humans ; Interdisciplinary Studies ; Technology
    Language English
    Publishing date 2022-06-14
    Publishing country England
    Document type Editorial
    ZDB-ID 4766-1
    ISSN 1873-5347 ; 0037-7856 ; 0277-9536
    ISSN (online) 1873-5347
    ISSN 0037-7856 ; 0277-9536
    DOI 10.1016/j.socscimed.2022.115059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Remaking critical care: Place, body work and the materialities of care in the COVID intensive care unit.

    Montgomery, Catherine M / Docherty, Annemarie B / Humphreys, Sally / McCulloch, Corrienne / Pattison, Natalie / Sturdy, Steve

    Sociology of health & illness

    2023  Volume 46, Issue 3, Page(s) 361–380

    Abstract: In this article, we take forward sociological ways of knowing care-in-practice, in particular work in critical care. To do so, we analyse the experiences of staff working in critical care during the first wave of the COVID-19 pandemic in the UK. This ... ...

    Abstract In this article, we take forward sociological ways of knowing care-in-practice, in particular work in critical care. To do so, we analyse the experiences of staff working in critical care during the first wave of the COVID-19 pandemic in the UK. This moment of exception throws into sharp relief the ways in which work and place were reconfigured during conditions of pandemic surge, and shows how critical care depends at all times on the co-constitution of place, practices and relations. Our analysis draws on sociological and anthropological work on the material culture of health care and its sensory instantiations. Pursuing this through a study of the experiences of 40 staff across four intensive care units (ICUs) in 2020, we provide an empirical and theoretical elaboration of how place, body work and care are mutually co-constitutive. We argue that the ICU does not exist independently of the constant embodied work of care and place-making which iteratively constitute critical care as a total system of relations.
    MeSH term(s) Humans ; COVID-19 ; Pandemics ; Intensive Care Units ; Critical Care
    Language English
    Publishing date 2023-09-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 795552-2
    ISSN 1467-9566 ; 0141-9889
    ISSN (online) 1467-9566
    ISSN 0141-9889
    DOI 10.1111/1467-9566.13708
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: How and why to use 'vulnerability': an interdisciplinary analysis of disease risk, indeterminacy and normality.

    Ford, Andrea / De Togni, Giulia / Erikainen, Sonja / Filipe, Angela Marques / Pickersgill, Martyn / Sturdy, Steve / Swallow, Julia / Young, Ingrid

    Medical humanities

    2024  Volume 50, Issue 1, Page(s) 125–134

    Abstract: In recent years, 'vulnerability' has been getting more traction in theoretical, professional and popular spaces as an alternative or complement to the concept of risk. As a group of science and technology studies scholars with different disciplinary ... ...

    Abstract In recent years, 'vulnerability' has been getting more traction in theoretical, professional and popular spaces as an alternative or complement to the concept of risk. As a group of science and technology studies scholars with different disciplinary orientations yet a shared concern with biomedicine, self and society, we investigate how vulnerability has become a salient and even dominant idiom for discussing disease and disease risk. We argue that this is at least partly due to an inherent indeterminacy in what 'vulnerability' means and does, both within and across different discourses. Through a review of feminist and disability theory, and a discussion of how vulnerability and disease both get recruited into a binary conceptualisation of normal versus abnormal, we argue that vulnerability's indeterminacy is, in fact, its strength, and that it should be used differently than risk. Using COVID-19 management in the UK as an illustration of the current ambivalence and ambiguity in how vulnerability versus risk is applied, we suggest that instead of being codified or quantified, as it has started to be in some biomedical and public health applications, vulnerability and its remedies should be determined in conjunction with affected communities and in ways that are polyvalent, flexible and nuanced. The concept of vulnerability encapsulates an important precept: we must recognise inequality as undesirable while not attempting to 'solve' it in deterministic ways. Rather than becoming fixed into labels, unidirectional causalities or top-down universalising metrics, vulnerability could be used to insist on relational, context-specific understandings of disease and disease risk-in line with contemporary social justice movements that require non-hierarchical and non-universal approaches to problems and solutions.
    MeSH term(s) Humans ; Concept Formation ; Social Justice ; Disabled Persons
    Language English
    Publishing date 2024-02-22
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 2018219-3
    ISSN 1473-4265 ; 1468-215X
    ISSN (online) 1473-4265
    ISSN 1468-215X
    DOI 10.1136/medhum-2023-012683
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Domesticating models: On the contingency of Covid-19 modelling in UK media and policy.

    Engelmann, Lukas / Montgomery, Catherine M / Sturdy, Steve / Moreno Lozano, Cristina

    Social studies of science

    2022  Volume 53, Issue 1, Page(s) 121–145

    Abstract: Our article traces the representation of pandemic modelling in UK print media from the emergence of Covid-19 to the early stages of implementing the first UK-wide lockdown in late March 2020. Covid modelling, it is widely assumed, has shaped policy ... ...

    Abstract Our article traces the representation of pandemic modelling in UK print media from the emergence of Covid-19 to the early stages of implementing the first UK-wide lockdown in late March 2020. Covid modelling, it is widely assumed, has shaped policy decisions and public responses to the pandemic in unprecedented ways. We analyse how the UK print media has configured modelling as a significant evidence tool in the representation of the pandemic. Interrogating assumptions about infectious disease modelling, we ask why models became the trusted tool of choice for knowing and responding to the Covid pandemic in the UK. Our analysis has yielded four different periods in the evolution of intersecting policy and media frames. Initially, modellers, policymakers and media alike emphasized uncertainty about available data, and hence the speculative character of modelled projections, thus justifying a 'wait and see' approach to government intervention. With growing public pressure for government action, policy and media frames were adjusted to emphasize the importance of timing interventions for best effect, with modelling evidence mobilized to justify inaction. This gave way to a period of crisis, as the press increasingly questioned the reliability of the existing models and policies, leading modellers and policy makers to dramatically revise their projections. Finally, with the imposition of the first UK lockdown, policy and media frames were brought back into alignment with one another, in a process of domestication through which the language of modelling became a basic resource for the discussion of the epidemic. Our epistemological microhistory thus challenges general accounts of the impacts of pandemic modelling and instead emphasizes contingency and interpretative flexibility.
    MeSH term(s) Humans ; COVID-19/epidemiology ; Reproducibility of Results ; Communicable Disease Control ; Health Policy ; Pandemics ; United Kingdom/epidemiology
    Language English
    Publishing date 2022-10-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1482712-8
    ISSN 1460-3659 ; 0306-3127
    ISSN (online) 1460-3659
    ISSN 0306-3127
    DOI 10.1177/03063127221126166
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Critical care work during COVID-19

    Corrienne Mcculloch / Catherine M Montgomery / Steve Sturdy

    BMJ Open, Vol 11, Iss

    a qualitative study of staff experiences in the UK

    2021  Volume 5

    Abstract: Objective To understand National Health Service (NHS) staff experiences of working in critical care during the first wave of the COVID-19 pandemic in the UK.Design Qualitative study using semistructured telephone interviews and rapid analysis, ... ...

    Abstract Objective To understand National Health Service (NHS) staff experiences of working in critical care during the first wave of the COVID-19 pandemic in the UK.Design Qualitative study using semistructured telephone interviews and rapid analysis, interpreted using Baehr’s sociological lens of ‘communities of fate’.Participants Forty NHS staff working in critical care, including 21 nurses, 10 doctors and advanced critical care practitioners, 4 allied health professionals, 3 operating department practitioners and 2 ward clerks. Participants were interviewed between August and October 2020; we purposefully sought the experiences of trained and experienced critical care staff and those who were redeployed.Setting Four hospitals in the UK.Results COVID-19 presented staff with a situation of extreme stress, duress and social emergency, leading to a shared set of experiences which we have characterised as a community of fate. This involved not only fear and dread of working in critical care, but also a collective sense of duty and vocation. Caring for patients and families involved changes to usual ways of working, revolving around: reorganisation of space and personnel, personal protective equipment, lack of evidence for treating COVID-19, inability for families to be physically present, and the trauma of witnessing extreme patient acuity and death on a large scale. The stress and isolation of working in critical care during COVID-19 was mitigated by strong teamwork, camaraderie, pride and fulfilment.Conclusion COVID-19 has changed working practices in critical care and profoundly affected staff physically, mentally and emotionally. Attention needs to be paid to the social and organisational conditions in which individuals work, addressing both practical resourcing and the interpersonal dynamics of critical care provision.
    Keywords Medicine ; R
    Subject code 360
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher BMJ Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: So long, succor.

    Sturdy, Steve

    Technology and culture

    2010  Volume 48, Issue 1, Page(s) 169–174

    MeSH term(s) Biomedical Technology ; Humans ; Knowledge ; Medicine ; Therapeutics ; Treatment Outcome ; Uncertainty
    Language English
    Publishing date 2010-07-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2021131-4
    ISSN 1097-3729 ; 0040-165X
    ISSN (online) 1097-3729
    ISSN 0040-165X
    DOI 10.1353/tech.2007.0042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.

    Huzair, Farah / Sturdy, Steve

    Studies in history and philosophy of biological and biomedical sciences

    2017  Volume 64, Page(s) 11–21

    Abstract: The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B ... ...

    Abstract The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic context that newly favoured commercialisation of academic research, including the appropriation and management of intellectual property; we elucidate the contingent interests and motivations that led new biotechnology companies and established pharmaceutical businesses to invest in developing recombinant vaccines specifically against hepatitis B; and we show how these and other factors combined to make those vaccines an unexpected commercial success. Broadening the scope of our analysis to include not just North America and Europe but also low- and middle-income countries, we show how the development of the hepatitis B vaccines facilitated the emergence of a two-tier innovation system structured by tensions between the demands for commercial profitability on the one hand, and the expectation of public health benefit for low- and middle-income countries on the other.
    MeSH term(s) Biotechnology/trends ; Diffusion of Innovation ; Hepatitis B/prevention & control ; Hepatitis B Vaccines ; Humans ; Public Health ; Vaccines
    Chemical Substances Hepatitis B Vaccines ; Vaccines
    Language English
    Publishing date 2017-05-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1500765-0
    ISSN 1879-2499 ; 1369-8486
    ISSN (online) 1879-2499
    ISSN 1369-8486
    DOI 10.1016/j.shpsc.2017.05.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top